At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Patent # | Description |
---|---|
US-9,861,624 |
Method of treating cancer This invention is directed to the treatment of cancer, particularly castration-resistant prostate cancer and osteolytic bone metastases, with a dual inhibitor... |
US-9,861,623 |
Combination treatment of RAS-positive diseases with PDE-.delta. inhibitor
and direct autophagy inhibitor The present invention provides methods for treatment of a RAS-positive disease, in particular KRAS-positive non-small cell lung cancer as well as a method for... |
US-9,861,622 |
Methods for treating disorders or diseases associated with hyperlipidemia
and hypercholesterolemia while... The present invention provides methods and compositions for treating hyperlipidemia and/or hypercholesterolemia comprising administering to the subject an... |
US-9,861,621 |
LPT-723 and immune checkpoint inhibitor combinations and methods of
treatment The present invention provides, inter alia, a composition containing a compound of formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof,... |
US-9,861,620 |
Substituted quinolizine derivatives useful as HIV integrase inhibitors The present invention relates to Substituted Quinolizine Derivatives of Formula (I): and pharmaceutically acceptable salts or prodrug thereof, wherein X, Y,... |
US-9,861,619 |
Antibiotic methods and compositions for bacteria infections Compositions and methods are provided for treating or inhibiting a bacterial infection involving at least one antibiotic and a compound that potentiates the... |
US-9,861,618 |
Thiazoles as modulators of ROR.gamma.t The present invention comprises compounds of Formula I ##STR00001## wherein: R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.7, R.sup.8, and ##STR00002## ... |
US-9,861,617 |
Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for
their use Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are... |
US-9,861,616 |
Methods for treating respiratory diseases and formulations therefor Compounds of formula (I), compositions comprising them, and methods and uses thereof are described herein for the treatment of respiratory diseases, including... |
US-9,861,615 |
Methods and pharmaceutical compositions for the treatment of
beta-thalassemias The present invention relates to methods and pharmaceutical compositions for the treatment of beta-thalassemias. In particular, the present invention relates to... |
US-9,861,614 |
Nuclear transport modulators and uses thereof The present invention relates to compounds of formula I: ##STR00001## and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the... |
US-9,861,613 |
GPR142 agonist compounds The present invention provides compounds of the Formula (Ia) wherein R is selected from the group consisting of CH.sub.3, CH(CH.sub.3).sub.2, CH.sub.2CN,... |
US-9,861,612 |
Indolyl-containing ROR.gamma.t inhibitors The invention relates to compounds of formula (I), wherein R.sup.1 and R.sup.2 are as defined herein. The compounds of the invention are inhibitors of... |
US-9,861,611 |
Formulations of water-soluble derivatives of vitamin E and soft gel
compositions, concentrates and powders... Provided herein are compositions that contain water-soluble vitamin E derivative mixtures (compositions), such as tocopheryl polyethylene glycol succinate... |
US-9,861,610 |
Process for selective extraction of bioactive and bioavailable cinnamon
polyphenols and procyanidin oligomers... The present invention relates to a process for selective extraction of bioactive and bioavailable cinnamon polyphenols and procyanidin oligomers of the type A... |
US-9,861,609 |
Chemical engineering processes and apparatus for the synthesis of
compounds The present invention provides methods for producing cannabinoids and cannabinoid analogs as well as a system for producing these compounds. The inventive... |
US-9,861,608 |
Methods for delivering cromolyn Methods of delivering cromolyn to a patient in need thereof, methods of treating amyloid-associated conditions and inflammatory or allergic lung diseases, and... |
US-9,861,607 |
Methods of using low-dose doxepin for the improvement of sleep Methods of preventing early awakenings, and improving sleep efficiency in hours 7 and 8 of a period of sleep, by administration of low doses of doxepin (e.g.,... |
US-9,861,606 |
Therapeutic for treating inflammatory lung disorders A calcium/cation-sensing receptor (CaSR) antagonist to treat an inflammatory lung disorder is described. Methods of treatment including the antagonist,... |
US-9,861,605 |
Enriched injectable emulsion containing selected fatty acid triglycerides A composition including a triglyceride containing glycerol which is esterified with three fatty acids, wherein the three fatty acids include at least one fatty... |
US-9,861,604 |
Coriolus versicolor extracts, methods of isolating biologically-active
compounds, and uses thereof The subject invention provides efficient and convenient methods of isolating 9-oxo-10E, 12E-octadecadienoic acid methyl ester (9-KODE methyl ester) from C.... |
US-9,861,603 |
Therapeutic compositions Ingenol angelate is a potent anticancer agent, and can be stabilized by dissolving it in an aprotic solvent in the presence of an acidic buffer. |
US-9,861,602 |
Compositions and methods comprising C16:1n7-palmitoleate One embodiment described herein is related to methods and compositions, such as nutraceutical formulations and dietary supplements, comprising ... |
US-9,861,601 |
Treatment of pulmonary arterial hypertension with leukotriene inhibitors Pulmonary arterial hypertension (PAH) can be prevented in persons susceptible to the diseases and PAH patients can be treated by administering an effective dose... |
US-9,861,600 |
Methods and compositions for treating and identifying compounds to treat
age-related macular degeneration treatment The present invention provides methods for treating or limiting development of age-related macular degeneration, as well as methods for identifying compound... |
US-9,861,599 |
Beta-substituted beta-amino acids and analogs as chemotherapeutic agents .beta.-Substituted .beta.-amino acids, .beta.-substituted .beta.-amino acid derivatives, and .beta.-substituted .beta.-amino acid analogs and (bio)isosteres and... |
US-9,861,598 |
Ketoprofen lysine salt-containing aqueous patch A ketoprofen-containing aqueous patch is provided in which not only operational efficiency in producing is improved, but also the aqueous patch has excellent... |
US-9,861,597 |
Gluconate-based compositions as a neonate anticonvulsant The present invention is drawn to the treatment of neonatal patients exhibiting convulsion comprising administering a composition comprising a gluconate... |
US-9,861,596 |
Compositions and methods for treating neurological diseases or injury Provided are compounds for the treatment of neurological diseases or injuries, including neurodegenerative diseases, stroke, trauma, epilepsy, acute and chronic... |
US-9,861,595 |
Compositions and methods for increasing the metabolic lifetime of
dextromethorphan and related pharmacodynamic... This disclosure relates to methods administering various compounds in conjunction with dextromethorphan to a human being. Dosage forms, drug delivery systems,... |
US-9,861,594 |
Treatments for attention and cognitive disorders, and for dementia
associated with a neurodegenerative disorder The present invention provides a method of treating or preventing an attention and/or cognitive disorder in a subject in need thereof, comprising administering... |
US-9,861,593 |
Method for treating or preventing dry eye disorders using
alkylamino-polyhydroxyalkanes Method for the treatment or prophylaxis of dry eye disorders by the administration of alkylamino-polyhydroxyalkanes and compositions thereof. |
US-9,861,592 |
Methods and compositions for treating neurodegenerative diseases The present invention provides methods and compositions for treating neurodegenerative diseases by cyclohexenone compounds. |
US-9,861,591 |
Nitric oxide-releasing wound treatment film and preparation method
therefor Provided is a nitric oxide-releasing wound treatment film containing S-nitroglutathione, which is a nitric oxide donor to be spontaneously formed in the human... |
US-9,861,590 |
Self-supporting films for delivery of therapeutic agents The present disclosure relates to self-supporting films for delivery of a therapeutic agent containing at least one hydrophobic polymer and at least one... |
US-9,861,589 |
Diester and triester based low molecular weight, biodegradeable cationic
lipids for oligonucleotide delivery The instant invention provides for novel cationic lipids of Formula A that can be used in combination with other lipid components such as cholesterol and... |
US-9,861,588 |
Nanoparticulate systems prepared from sorbitan esters The invention relates to systems comprising homogenous nanoparticles having an average size of less than 1 micrometer and containing at least a sorbitan ester,... |
US-9,861,587 |
Composition and method for treating ketosis in cows A method for prophylactic treatment of ketosis in a calving cow, the method including orally administering to the cow within a time period of about 12 hours... |
US-9,861,586 |
Chewable soft capsules A matrix formulation for a soft chewable capsule is provided which includes a gel-forming composition, a plasticizer, a polymer modifier, and water. The polymer... |
US-9,861,585 |
Osmotic floating tablets The present invention relates to an osmotic floating tablet comprising: (i) an inner core comprising a drug, one or more low density polymers, and one or more... |
US-9,861,584 |
Tamper resistant controlled release dosage forms In certain embodiments, the present invention is directed to a solid controlled release dosage form comprising: a core comprising a first portion of an opioid... |
US-9,861,583 |
Pharmaceutical formulation containing gelling agent Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together... |
US-9,861,582 |
Pharmaceutical formulation containing gelling agent Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together... |
US-9,861,581 |
Granulate for the formulation of orodispersible tablets This invention relates to a granulate comprising mannitol and sorbitol in a weight ratio of between 70:30 and 97:3. This invention also relates to the use of a... |
US-9,861,580 |
Method of making a dry powder pharmaceutical composition A method of making active pharmaceutical ingredient particles with surface-modified nanoparticles deposited on the particles' surfaces, the method comprising:... |
US-9,861,579 |
Foamable formulation The present invention provides DMSO-containing foamable formulations, methods for preparation, and methods of treatment. The formulations can provide good... |
US-9,861,578 |
Sublingual dosimetric drip caged ball valve device A device for self-administration of fractional amounts of a total volume dose of liquid medicament supplied from a capsule over a period of time for delivery to... |
US-9,861,577 |
Orally disintegrating tablet It is an object of the present invention to provide an orally disintegrating tablet that has desirable oral disintegrability and excellent tablet hardness, a... |
US-9,861,576 |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses
thereof Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to... |
US-9,861,575 |
Vitamin-containing nutrition infusion for administration through
peripheral vein A nutrition infusion is provided for administration through a peripheral vein that contains a vitamin B group and vitamin C stably and includes two solutions of... |